<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03939832</url>
  </required_header>
  <id_info>
    <org_study_id>FiO2 CPB</org_study_id>
    <nct_id>NCT03939832</nct_id>
  </id_info>
  <brief_title>FiO2 and Outcomes After Cardiac Surgery With Cardiopulmonary Bypass</brief_title>
  <official_title>Effect of Intraoperative Oxygen Tension on Patient Outcomes After Cardiac Surgery With Cardiopulmonary Bypass: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Conventionally, a relatively high level of fraction of inspired oxygen (FiO2) has been used
      for secure a margin of safety in patients undergoing cardiac surgery using cardiopulmonary
      bypass (CPB). Since the potential adverse effects of hyperoxemia (via reactive oxygen
      species, vasocontriction, perfusion heterogeneity, myocardiac injury, etc.), various studies
      on this topic has been performed. However, the results are conflicting and inconsistent, and
      the consensus about whether the use of additional oxygen supply in cardiac surgery using CPB
      has not been reached among practitioners yet.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 4, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hospital LOS</measure>
    <time_frame>From the beginning of surgery until the hospital discharge after surgery through study completion, an expected average of two weeks</time_frame>
    <description>length of hospital stay after cardiac surgery using cardiopulmonary bypass</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Patients Undergoing Cardiac Surgery Using Cardiopulmonary Bypass</condition>
  <arm_group>
    <arm_group_label>FiO2 0.5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>FiO2 1.0</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fraction of inspired oxygen level</intervention_name>
    <description>A fraction of inspired oxygen level during cardiac surgery using cardiopulmonary bypass will be set differently: 0.5 versus 1.0.</description>
    <arm_group_label>FiO2 0.5</arm_group_label>
    <arm_group_label>FiO2 1.0</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients scheduled for cardiac surgery using cardiopulmonary bypass

        Exclusion Criteria:

          -  Planned implementation of deep hypothermic circulatory arrest

          -  Preoperative respiratory support with the fraction of inspired oxygen of 0.5 and more.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yunseok Jeon</last_name>
    <phone>+82 2 2072 3108</phone>
    <email>jeonyunseok@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunseok Jeon</last_name>
      <phone>+82 2 2072 3108</phone>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 3, 2019</study_first_submitted>
  <study_first_submitted_qc>May 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2019</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Yunseok Jeon</investigator_full_name>
    <investigator_title>Professor of Anesthesiology and Pain Medicine</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

